SBB

System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

Product code

SBB

Device name

System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection

Device class

Class 3

Medical specialty

Unknown

Marketing pathway

PMA

FDA classification definition

The colorectal neoplasia RNA and hemoglobin assay is a non-invasive, qualitative in vitro diagnostic intended for the detection of colorectal neoplasia associated RNA markers and for the presence of occult hemoglobin in human stool. The test is to aid in the detection of colorectal cancer (CRC) and advanced adenomas (AA). The test is not a replacement for diagnostic colonoscopy. It is indicated for use in adults 45 years or older, who are typical average-risk candidates for colorectal cancer (CRC) screening. A positive result may indicate the presence of CRC or AA and should be followed by a diagnostic colonoscopy.

Definition text from the FDA device classification database (U.S. federal government work, public domain).